Risk of kava hepatotoxicity and the FDA consumer advisory.
about
Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisitedHerbal Hepatotoxicity: Clinical Characteristics and Listing CompilationHepatotoxicity Induced by "the 3Ks": Kava, Kratom and KhatThe Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and ChallengesUpdates on Nutraceutical Sleep Therapeutics and Investigational ResearchHerbal hepatotoxicity: challenges and pitfalls of causality assessment methodsKava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence.Commonly Used Dietary Supplements on Coagulation Function during SurgeryHerbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging stepsCytochrome P450 enzyme mediated herbal drug interactions (Part 2)Review article: herbal and dietary supplement hepatotoxicity.Clinical and causality assessment in herbal hepatotoxicity.Drug-induced hepatotoxicity of select herbal therapies.Is driving under the influence of kava associated with motor vehicle crashes? A systematic review of the epidemiological literature.Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs.
P2860
Q24599507-6B527675-8E35-4C42-8144-002A0D2303E3Q26748874-658E82FD-12D4-438D-A656-752D5B2DE2B2Q26752375-588B80E0-9981-4B27-BB70-D929C2B4C323Q26752620-0B7797C9-870C-43E4-9BF6-87B9A390BE29Q26799049-A976F502-C9F1-48ED-9BB2-422D0EBFA629Q26824747-D8F74014-AB44-42EE-B3AE-795CB7B0DC85Q34173744-DDF6AD91-DAF7-442E-ADF4-FA1395EBF67EQ34517159-E6CDA883-F5ED-4A69-AFE4-B3C13F1851B2Q35531281-BD5EBBD4-47C5-486C-B595-94D93A7F0E27Q35729029-F644CB08-B303-4876-9DA9-02596C16CCF0Q38057354-96B30F21-0E11-47E4-894A-D442A03592E2Q38086300-7063875A-E9D8-431A-90E9-302EB79BB99FQ38302838-65947D45-0DF4-4848-85DD-0467FBC8082BQ38580292-D0E7A0AF-94CE-4FB6-814C-F34568B7B7B9Q41747844-32713C80-CB2D-47C9-A69E-0E585B1BB2FF
P2860
Risk of kava hepatotoxicity and the FDA consumer advisory.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk of kava hepatotoxicity and the FDA consumer advisory.
@ast
Risk of kava hepatotoxicity and the FDA consumer advisory.
@en
Risk of kava hepatotoxicity and the FDA consumer advisory.
@nl
type
label
Risk of kava hepatotoxicity and the FDA consumer advisory.
@ast
Risk of kava hepatotoxicity and the FDA consumer advisory.
@en
Risk of kava hepatotoxicity and the FDA consumer advisory.
@nl
prefLabel
Risk of kava hepatotoxicity and the FDA consumer advisory.
@ast
Risk of kava hepatotoxicity and the FDA consumer advisory.
@en
Risk of kava hepatotoxicity and the FDA consumer advisory.
@nl
P356
P1476
Risk of kava hepatotoxicity and the FDA consumer advisory.
@en
P2093
Johannes Schulze
Rolf Teschke
P304
P356
10.1001/JAMA.2010.1689
P407
P577
2010-11-01T00:00:00Z